GlassScriptPhysician profile
Lanny Douglas
NPI 1427159664
$5,530.16
in general payments reported to CMS, 2019-2025
18 companies · $1,086 in 2025
The $1,086 reported for 2025 was more than what 78% of Psychiatric/Mental Health (Clinical Nurse Specialist) providers received nationally (typical 2025 total: $244).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,390 · 2022: $1,077 · 2023: $896 · 2024: $1,082 · 2025: $1,086.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,064.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,063.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $1,496.78 | 2021-2025 | Caplyta |
| Neurocrine Biosciences, INC. | $1,145.21 | 2021-2025 | Ingrezza |
| Abbvie INC. | $613.39 | 2021-2024 | |
| Takeda Pharmaceuticals U.S.A., INC. | $369.90 | 2021-2025 | Trintellix |
| Teva Pharmaceuticals USA, INC. | $351.64 | 2023-2024 | Austedo Xr, Uzedy, Austedo |
| Otsuka America Pharmaceutical, INC. | $304.74 | 2021-2024 | Rexulti, Abilify Asimtufii, Abilify Maintena |
| Sunovion Pharmaceuticals INC. | $261.19 | 2021-2022 | |
| Lundbeck LLC | $192.66 | 2021-2023 | Rexulti |
| Corium, LLC | $140.95 | 2023 | Azstarys |
| Alkermes, INC. | $112.14 | 2021-2022 | |
| Adlon Therapeutics L.P. | $107.90 | 2021 | |
| Eisai INC. | $102.39 | 2021-2022 | |
| Janssen Pharmaceuticals, INC | $89.78 | 2022-2023 | Spravato |
| E.R. Squibb & Sons, L.L.C. | $86.13 | 2025 | Cobenfy |
| Alfasigma USA, INC. | $71.48 | 2021-2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avanir Pharmaceuticals, INC. | $42.87 | 2021-2022 | |
| Axsome Therapeutics, INC. | $29.13 | 2023 | Auvelity |
| Noven Pharmaceuticals, INC. | $11.88 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lanny Douglas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.